|
|
|
Volumn Suppl, Issue , 2002, Pages 6-
|
|
Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
SIMVASTATIN;
ARTICLE;
CEREBROVASCULAR ACCIDENT;
CONTROLLED CLINICAL TRIAL;
HEART INFARCTION;
HUMAN;
UNITED KINGDOM;
ANTICHOLESTEREMIC AGENTS;
CEREBROVASCULAR ACCIDENT;
CONTROLLED CLINICAL TRIALS;
ENGLAND;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MYOCARDIAL INFARCTION;
SIMVASTATIN;
|
|
EID: 0036362495
PISSN: 10961860
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
